|
Piramal Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
22022.98 Cr.
|
P/BV
|
2.78
|
Book Value (Rs.)
|
59.53
|
|
52 Week High/Low (Rs.)
|
273/167
|
FV/ML
|
10/1
|
P/E(X)
|
241.87
|
|
Bookclosure
|
16/07/2025
|
EPS (Rs.)
|
0.69
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.69 | 0.14 | -1.57 | 3.19 | 18.56 |
| Diluted EPS (Rs.) | 0.68 | 0.14 | -1.57 | 3.19 | 18.56 |
| Cash EPS (Rs.) | 6.30 | 5.28 | 3.65 | 7.62 | 13.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 |
| Revenue From Operations / Share (Rs.) | 69.10 | 61.76 | 59.34 | 55.31 | 63.49 |
| PBDIT / Share (Rs.) | 11.93 | 10.37 | 7.15 | 10.33 | 16.01 |
| PBIT / Share (Rs.) | 5.76 | 4.77 | 1.48 | 5.39 | 10.53 |
| PBT / Share (Rs.) | 2.58 | 0.90 | -1.46 | 3.59 | 9.07 |
| Net Profit / Share (Rs.) | 0.13 | -0.31 | -2.02 | 2.67 | 7.92 |
| NP After MI And SOA / Share (Rs.) | 0.68 | 0.13 | -1.56 | 3.17 | 8.39 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 17.26 | 16.78 | 12.05 | 18.68 | 25.21 |
| PBIT Margin (%) | 8.34 | 7.72 | 2.49 | 9.74 | 16.58 |
| PBT Margin (%) | 3.73 | 1.46 | -2.46 | 6.49 | 14.28 |
| Net Profit Margin (%) | 0.19 | -0.50 | -3.40 | 4.83 | 12.47 |
| NP After MI And SOA Margin (%) | 0.99 | 0.21 | -2.63 | 5.73 | 13.22 |
| Return on Networth / Equity (%) | 1.12 | 0.22 | -2.75 | 5.61 | 14.89 |
| Return on Capital Employeed (%) | 6.40 | 5.76 | 1.65 | 6.54 | 12.45 |
| Return On Assets (%) | 0.58 | 0.11 | -1.28 | 2.93 | 7.66 |
| Long Term Debt / Equity (X) | 0.39 | 0.31 | 0.49 | 0.39 | 0.41 |
| Total Debt / Equity (X) | 0.58 | 0.57 | 0.81 | 0.60 | 0.48 |
| Asset Turnover Ratio (%) | 0.59 | 0.54 | 0.33 | 0.34 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.54 | 1.25 | 1.26 | 1.34 | 1.47 |
| Quick Ratio (X) | 0.92 | 0.75 | 0.82 | 0.88 | 0.97 |
| Inventory Turnover Ratio (X) | 4.08 | 1.02 | 1.06 | 1.17 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 15.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 84.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 98.41 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 3.75 | 3.06 | 2.48 | 6.18 | 9.74 |
| Interest Coverage Ratio (Post Tax) (%) | 1.04 | 1.05 | 0.32 | 2.67 | 5.71 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 33950.47 | 21129.13 | 13363.10 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 3.71 | 2.59 | 1.89 | 0.00 | 0.00 |
| EV / EBITDA (X) | 21.49 | 15.40 | 15.66 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 |
| Retention Ratios (%) | 84.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.66 | 2.16 | 1.21 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 |
| EarningsYield | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
